Your browser doesn't support javascript.
loading
The Potential Relationship Between Cardiovascular Diseases and Monkeypox.
Zeng, Guang-Gui; Jiang, Wan-Li; Yu, Jiang; Nie, Gui-Ying; Lu, Yu-Ru; Xiao, Chang-Kai; Wang, Chuan; Zheng, Kang.
Afiliação
  • Zeng GG; Department of Clinical Laboratory, Hengyang Central Hospital, Hengyang, Hunan, China; Institute of Pathogenic Biology, Hengyang Medical College, University of South China, Hengyang, Hunan, China; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, 2020 Grade
  • Jiang WL; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, 2020 Grade Excellent Doctor Class of Hengyang Medical College, University of South China, Hengyang, Hunan, China.
  • Yu J; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, 2020 Grade Excellent Doctor Class of Hengyang Medical College, University of South China, Hengyang, Hunan, China.
  • Nie GY; Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, 2020 Grade Excellent Doctor Class of Hengyang Medical College, University of South China, Hengyang, Hunan, China.
  • Lu YR; Department of Emergency Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Department of Intensive Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Xiao CK; Department of Urology, Hengyang Medical School, The First Affiliated Hospital, University of South China, Hengyang, Hunan, China.
  • Wang C; Institute of Pathogenic Biology, Hengyang Medical College, University of South China, Hengyang, Hunan, China. Electronic address: wangchuan@usc.edu.cn.
  • Zheng K; Department of Clinical Laboratory, Hengyang Central Hospital, Hengyang, Hunan, China. Electronic address: zhengkang1221@sina.com.
Curr Probl Cardiol ; 49(1 Pt C): 102116, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37802168
ABSTRACT
Mpox, a novel epidemic disease, has broken out the period of coronavirus disease 2019 since May 2022, which was caused by the mpox virus. Up to 12 September 2023, there are more than 90,439 confirmed mpox cases in over 115 countries all over the world. Moreover, the outbreak of mpox in 2022 was verified to be Clade II rather than Clade I. Highlighting the significance of this finding, a growing body of literature suggests that mpox may lead to a series of cardiovascular complications, including myocarditis and pericarditis. It is indeed crucial to acquire more knowledge about mpox from a perspective from the clinical cardiologist. In this review, we would discuss the epidemiological characteristics and primary treatments of mpox to attempt to provide a framework for cardiovascular physicians.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pericardite / Doenças Cardiovasculares / Mpox / COVID-19 / Miocardite Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pericardite / Doenças Cardiovasculares / Mpox / COVID-19 / Miocardite Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article